Nasdaq Set to Beat NYSE in IPO Race for Fifth Year in a Row

Nasdaq is on track to beat the New York Stock Exchange in the battle for initial…

WSJ News Exclusive | CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling Them

Updated Oct. 20, 2023 11:00 am ET CVS Health is pulling some of the most common…

The IPO Market Is Open Again—at Least for the Moment

Arm, Instacart and Klaviyo all popped on their first day of trading, but their performance since…

J&J’s $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion 

The healthcare giant’s separation of its consumer-health business arms it with billions in cash for allocating…

Johnson & Johnson Rips Off the Kenvue Band-Aid

The surprisingly quick delivery and extended evaluation hit J&J’s consumer health arm hard.

Surge in Heart Procedures Helps Drive Johnson & Johnson Revenue

The pharmaceutical company’s net income rose 6.9% to $5.14 billion, or $1.96 per share.